<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2026-04-06-04:00" xsi:noNamespaceSchemaLocation="https://www.reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>0960-AH43</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>201410</PUBLICATION_ID>
            <PUBLICATION_TITLE>The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>0960</CODE>
            <NAME>Social Security Administration</NAME>
            <ACRONYM>SSA</ACRONYM>
        </AGENCY>
        <RULE_TITLE>Revised Medical Criteria for Evaluating Cancer (Malignant Neoplastic Diseases) (3757F)</RULE_TITLE>
        <ABSTRACT><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sections 13.00 and 113.00, Malignant Neoplastic Diseases, of appendix 1 to subpart P of our regulations describe malignant neoplastic diseases that we consider severe enough to prevent an individual from doing any gainful activity or that cause marked and severe functional limitations for a child claiming SSI payments under title XVI. We will revise these sections to ensure that the medical evaluation criteria are up-to-date and consistent with the latest advances in medical knowledge and treatment.</p>
</body>
</html>]]></ABSTRACT>
        <PRIORITY_CATEGORY>Other Significant</PRIORITY_CATEGORY>
        <RIN_STATUS>Previously Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Final Rule Stage</RULE_STAGE>
        <MAJOR>No</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <CFR_LIST>
            <CFR>20 CFR 404.1500, app 1</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>42 USC 402</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 405(a)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 405(b)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 405(d) to 405(h)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 405(h)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 416(i)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 421(a)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 421(i)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 423</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 902(a)(5)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 1381a</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 1382c</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 1383</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 1383b</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST/>
        <RPLAN_ENTRY>Yes</RPLAN_ENTRY>
        <RPLAN_INFO>
            <STMT_OF_NEED><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>These final regulations are necessary to update the Malignant Neoplastic Diseases listings to reflect advances in medical knowledge, treatment, and methods of evaluating malignant neoplastic diseases. The changes will ensure that determinations of disability have a sound medical basis, that claimants receive equal treatment through the use of specific criteria, and that people who are disabled can be readily identified and awarded benefits if all other factors of entitlement or eligibility are met.</p>
</body>
</html>]]></STMT_OF_NEED>
            <LEGAL_BASIS><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Administrative--not required by statute or court order.</p>
</body>
</html>]]></LEGAL_BASIS>
            <ALTERNATIVES><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>We considered not revising the listings and continuing to use our current criteria. However, we believe that these revisions are preferable because of the medical advances that have been made in treating and evaluating these malignant neoplastic diseases and because of our adjudicative experience.</p>
</body>
</html>]]></ALTERNATIVES>
            <COSTS_AND_BENEFITS><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Estimated costs--low.</p>
</body>
</html>]]></COSTS_AND_BENEFITS>
            <RISKS><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>None.</p>
</body>
</html>]]></RISKS>
        </RPLAN_INFO>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>NPRM</TTBL_ACTION>
                <TTBL_DATE>12/17/2013</TTBL_DATE>
                <FR_CITATION>78 FR 76508</FR_CITATION>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>NPRM Comment Period End</TTBL_ACTION>
                <TTBL_DATE>02/18/2014</TTBL_DATE>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>Final Action</TTBL_ACTION>
                <TTBL_DATE>06/00/2015</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <RFA_REQUIRED>No</RFA_REQUIRED>
        <SMALL_ENTITY_LIST>
            <SMALL_ENTITY>No</SMALL_ENTITY>
        </SMALL_ENTITY_LIST>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>None</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <FEDERALISM>No</FEDERALISM>
        <ENERGY_AFFECTED>No</ENERGY_AFFECTED>
        <PUBLIC_COMMENT_URL> www.regulations.gov</PUBLIC_COMMENT_URL>
        <PRINT_PAPER>No</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>No</INTERNATIONAL_INTEREST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Cheryl</FIRST_NAME>
                <LAST_NAME>Williams</LAST_NAME>
                <MIDDLE_NAME>A.</MIDDLE_NAME>
                <TITLE>Director</TITLE>
                <AGENCY>
                    <CODE>0960</CODE>
                    <NAME>Social Security Administration</NAME>
                    <ACRONYM>SSA</ACRONYM>
                </AGENCY>
                <PHONE>410 965-1020</PHONE>
                <EMAIL>cheryl.a.williams@ssa.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>Office of Medical Policy, 6401 Security Boulevard,</STREET_ADDRESS>
                    <CITY>Baltimore</CITY>
                    <STATE>MD</STATE>
                    <ZIP>21235-6401</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
            <CONTACT>
                <FIRST_NAME>Mark</FIRST_NAME>
                <LAST_NAME>Kuhn</LAST_NAME>
                <TITLE>Social Insurance Specialist</TITLE>
                <AGENCY>
                    <CODE>0960</CODE>
                    <NAME>Social Security Administration</NAME>
                    <ACRONYM>SSA</ACRONYM>
                </AGENCY>
                <PHONE>410 966-6109</PHONE>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>Office of Medical Listings Improvement, 6401 Security Boulevard,</STREET_ADDRESS>
                    <CITY>Baltimore</CITY>
                    <STATE>MD</STATE>
                    <ZIP>21235-6401</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
            <CONTACT>
                <FIRST_NAME>Brian</FIRST_NAME>
                <LAST_NAME>Rudick</LAST_NAME>
                <TITLE>Social Insurance Specialist, Regulations Writer</TITLE>
                <AGENCY>
                    <CODE>0960</CODE>
                    <NAME>Social Security Administration</NAME>
                    <ACRONYM>SSA</ACRONYM>
                </AGENCY>
                <PHONE>410 965-1483</PHONE>
                <EMAIL>brian.rudick@ssa.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>Office of Regulations and Reports Clearance, 6401 Security Boulevard,</STREET_ADDRESS>
                    <CITY>Baltimore</CITY>
                    <STATE>MD</STATE>
                    <ZIP>21235-6401</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
